Centene appoints Cressey’s Paul Diaz to board as Burdick retires - CNC News | RalliesCentene appoints Cressey’s Paul Diaz to board as Burdick retires
C
CNC• Centene board changes take effect July 28, 2026
- Centene disclosed board changes effective July 28, 2026.
- Kenneth A. Burdick retired from the board; he joined in January 2022.
- Paul J. Diaz joined the board; he is managing partner at Cressey & Company.
- Diaz previously led Myriad Genetics as CEO; earlier served as CEO of Kindred Healthcare.
IPAR
•
